Abstract
High circulating glucose has been associated with increased risk of breast cancer (BC). There may also be a link between serum glucose and prognosis in women treated for BC. We assessed the effect of peridiagnostic fasting blood glucose and body mass index (BMI) on long-term BC prognosis. We retrospectively investigated 1,261 women diagnosed and treated for stage I–III BC at the National Cancer Institute, Milan, in 1996, 1999 and 2000. Data on blood tests and follow-up were obtained by linking electronic archives, with follow-up to end of 2009. Multivariate Cox modelling estimated hazard ratios (HR) with 95 % confidence intervals (CI) for distant metastasis, recurrence and death (all causes) in relation to categorized peridiagnostic fasting blood glucose and BMI. Mediation analysis investigated whether blood glucose mediated the BMI-breast cancer prognosis association. The risks of distant metastasis were significantly higher for all other quintiles compared to the lowest glucose quintile (reference <87 mg/dL) (respective HRs: 1.99 95 % CI 1.23–3.24, 1.85 95 % CI 1.14–3.0, 1.73 95 % CI 1.07–2.8, and 1.91 95 % CI 1.15–3.17). The risk of recurrence was significantly higher for all other glucose quintiles compared to the first. The risk of death was significantly higher than reference in the second, fourth and fifth quintiles. Women with BMI ≥ 25 kg/m2 had significantly greater risks of recurrence and distant metastasis than those with BMI < 25 kg/m2, irrespective of blood glucose. The increased risks remained invariant over a median follow-up of 9.5 years. Mediation analysis indicated that glucose and BMI had independent effects on BC prognosis. Peridiagnostic high fasting glucose and obesity predict worsened short- and long-term outcomes in BC patients. Maintaining healthy blood glucose levels and normal weight may improve prognosis.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- HR:
-
Hazard ratio
- CI:
-
Confidence interval
- BC:
-
Breast cancer
- NCIM:
-
National Cancer Institute of Milan
References
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Koroljow S (1962) Two cases of malignant tumors with metastases apparently treated successfully with hypoglycemic coma. Psychiatr Q 36:261–270
Carroll KK (1977) Dietary factors in hormone-dependent cancers. Curr Concepts Nutr 6:25–40
Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11(11):1361–1368
Sieri S, Muti P, Claudia A, Berrino F, Pala V, Grioni S, Abagnato CA, Blandino G, Contiero P, Schunemann HJ, Krogh V (2012) Prospective study on the role of glucose metabolism in breast cancer occurrence. Int J Cancer 130(4):921–929
Holmes MD, Liu S, Hankinson SE, Colditz GA, Hunter DJ, Willett WC (2004) Dietary carbohydrates, fiber, and breast cancer risk. Am J Epidemiol 159(8):732–739
Miao Jonasson J, Cederholm J, Eliasson B, Zethelius B, Eeg-Olofsson K, Gudbjörnsdottir S (2012) HbA1C and cancer risk in patients with type 2 diabetes–a nationwide population-based prospective cohort study in Sweden. PLoS One 7(6):e38784. doi:10.1371/journal.pone.0038784
Garber K (2004) Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst 96(24):1805–1806
Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24(2):68–72
Sun Y (1990) Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 8(6):583–599
Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445
Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202(3):654–662
Krzeslak A, Wojcik-Krowiranda K, Forma E, Jozwiak P, Romanowicz H, Bienkiewicz A, Brys M (2012) Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers. Pathol Oncol Res 18(3):721–728
Zeng L, Biernacka KM, Holly JM, Jarrett C, Morrison AA, Morgan A, Winters ZE, Foulstone EJ, Shield JP, Perks CM (2010) Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. Endocr Relat Cancer 17(2):539–551
Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119(1):236–238
Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, Ambs A, Ballard-Barbash R, Neuhouser ML (2011) Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomarkers Prev 20(5):890–899
Krone CA, Ely JT (2005) Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther 4(1):25–31
Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Taylor SK, Hood N (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30(2):164–171
Contiero P, Tittarelli A, Tagliabue G, Maghini A, Fabiano S, Crosignani P, Tessandori R (2005) The EpiLink record linkage software: presentation and results of linkage test on cancer registry files. Methods Inf Med 44(1):66–71
Tagliabue G, Maghini A, Fabiano S, Tittarelli A, Frassoldi E, Costa E, Nobile S, Codazzi T, Crosignani P, Tessandori R, Contiero P (2006) Consistency and accuracy of diagnostic cancer codes generated by automated registration: comparison with manual registration. Popul Health Metr 4:10
Therneau TM, Grambsch PM (2000) Testing proportional hazards. In: Modeling survival data: extending the Cox model. Springer, New York
Bellera CA, MacGrogan G, Debled M, de Lara CT, Brouste V, Mathoulin-Pélissier S (2010) Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer. BMC Med Res Methodol 10:20
MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V (2002) A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 7(1):83–104
Freedman LS, Schatzkin A (1992) Sample size for studying intermediate endpoints within intervention trails or observational studies. Am J Epidemiol 136(9):1148–1159
R Development Core Team (2007), R: a language and environment for statistical computing. http://www.r-project.org
Ewertz M, Jensen MB, Gunnarsdóttir KÁ, Højris I, Jakobsen EH, Nielsen D, Stenbygaard LE, Tange UB, Cold S (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29(1):25–31
de Azambuja E, McCaskill-Stevens W, Francis P, Quinaux E, Crown JP, Vicente M, Giuliani R, Nordenskjöld B, Gutiérez J, Andersson M, Vila MM, Jakesz R, Demol J, Dewar J, Santoro A, Lluch A, Olsen S, Gelber RD, Di Leo A, Piccart-Gebhart M (2010) The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02–98 trial. Breast Cancer Res Treat 119(1):145–153
Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123(3):627–633
Monteiro CA, Cannon G (2012) The impact of transnational “big food” companies on the South: a view from Brazil. PLoS Med 9(7):e1001252. doi:10.1371/journal.pmed.1001252
Igumbor EU, Sanders D, Puoane TR, Tsolekile L, Schwarz C, Purdy C, Swart R, Durão S, Hawkes C (2012) “Big food,” the consumer food environment, health, and the policy response in South Africa. PLoS Med 9(7):e1001253. doi:10.1371/journal.pmed.1001253
Stuckler D, McKee M, Ebrahim S, Basu S (2012) Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med 9(6):e1001235. doi:10.1371/journal.pmed.1001235
Wang H, Wang J, Liu MM, Wang D, Liu YQ, Zhao Y, Huang MM, Liu Y, Sun J, Dong GH (2012) Epidemiology of general obesity, abdominal obesity and related risk factors in urban adults from 33 communities of northeast china: the CHPSNE study. BMC Public Health 12:967
Levy RB, Claro RM, Bandoni DH, Mondini L, Monteiro CA (2012) Availability of added sugars in Brazil: distribution, food sources and time trends. Rev Bras Epidemiol 15(1):3–12
World Health Organization (2006) Obesity and overweight. Fact sheet number 311. World Health Organization, Geneva
Acknowledgments
The authors thank Don Ward for help with the English and for critically reviewing the manuscript. This study was supported by the National Cancer Institute at the National Institutes of Health grant ‘Fasting Glucose in Long Term Breast Cancer Survival’ (1R21 CA 106905 01).
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Contiero, P., Berrino, F., Tagliabue, G. et al. Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study. Breast Cancer Res Treat 138, 951–959 (2013). https://doi.org/10.1007/s10549-013-2519-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-013-2519-9